ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 12.40
+0.45 (3.77%)
Sep 30, 2026, 3:00 PM CST
SHA:600479 Revenue
ZhuZhou QianJin Pharmaceutical Co.,Ltd had revenue of 948.03M CNY in the quarter ending June 30, 2026, with 16.61% growth. This brings the company's revenue in the last twelve months to 3.73B, up 5.84% year-over-year. In the year 2025, ZhuZhou QianJin Pharmaceutical Co.,Ltd had annual revenue of 3.63B, down -0.03%.
Revenue (ttm)
3.73B
Revenue Growth
+5.84%
P/S Ratio
1.64
Revenue / Employee
739.76K
Employees
5,041
Market Cap
6.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.63B | -961.39K | -0.03% |
| Dec 31, 2024 | 3.63B | -168.68M | -4.44% |
| Dec 31, 2023 | 3.80B | -227.79M | -5.66% |
| Dec 31, 2022 | 4.03B | 362.43M | 9.89% |
| Dec 31, 2021 | 3.66B | 36.88M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.64B |
| Guizhou Xinbang Pharmaceutical | 5.24B |
| KPC Pharmaceuticals,Inc. | 4.87B |
| Hunan Jiudian Pharmaceutical | 2.89B |
| Shandong Wit Dyne Health | 1.91B |
| Beijing Beilu Pharmaceutical | 1.29B |
| Jiangsu Jibeier Pharmaceutical | 1.00B |
| Chongqing Pharscin Pharmaceutical | 798.78M |